CoChat

Thiazolidinediones induce osteocyte apoptosis and increase sclerostin expression

Open access
Mabilleau, G., Mieczkowska, A., Edmonds, M. E. · 2010 · Diabetic Medicine
Cited by 58

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Diabet. Med. 27, 925–932 (2010) Aims Thiazolidinediones (TZDs) are associated with a higher risk of bone fracture in women compared with men. The aim of the present study was to investigate whether TZDs could influence osteocyte behaviour and contribute to the skeletal phenotype observed in TZD‐treated patients. Methods The murine MLO‐Y4 cell line was used as a source of osteocytes. These cells were cultured for 24 h with 0, 10−8 m, 10−7 m, 10−6 m, 10−5 m or 10−4 m of pioglitazone, rosiglitazone or troglitazone in the presence or absence of 17β‐oestradiol. The extent of osteocyte apoptosis was assessed, as was the expression of the bone formation inhibitor sclerostin and receptor activator for nuclear factor κB ligand (RANKL) also. Results In the absence of 17β‐oestradiol, pioglitazone, rosiglitazone and troglitazone induced osteocyte apoptosis dose‐dependently even at the lowest concentration of 10−8 m. Furthermore, the expression of sclerostin but not RANKL was significantly increased in TZD‐treated cultures compared with untreated cultures. The presence of 17β‐oestradiol significantly reduced TZD‐induced osteocyte apoptosis and also sclerostin up‐regulation. Conclusions These findings therefore raise the potential concern of using TZDs in post‐menopausal women where the lack of oestrogen would not prevent osteocyte apoptosis and sclerostin up‐regulation and may aggravate the reduction in bone mass in these patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2010.03048.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 58

Metadata

Authors
Mabilleau, G., Mieczkowska, A., & Edmonds, M. E.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2010-07-15
Volume
27
Issue
8
Pages
925-932
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W1602216268
Cited by
58
References
5
FWCI
4.89
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.